{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:54:02Z","timestamp":1792857242301,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T00:00:00Z","timestamp":1524182400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T00:00:00Z","timestamp":1524182400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R25 NS065723"],"award-info":[{"award-number":["R25 NS065723"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001459","name":"American Medical Association Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001459","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-15-003-01-CCE"],"award-info":[{"award-number":["RSG-15-003-01-CCE"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001453","name":"American Brain Tumor Association","doi-asserted-by":"publisher","award":["ARC1700002"],"award-info":[{"award-number":["ARC1700002"]}],"id":[{"id":"10.13039\/100001453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001512","name":"National Brain Tumor Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001512","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1P50CA211015-01A1"],"award-info":[{"award-number":["1P50CA211015-01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R21CA223757-01"],"award-info":[{"award-number":["1R21CA223757-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s11060-018-2877-6","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T05:53:17Z","timestamp":1524203597000},"page":"399-409","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["18F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-na\u00efve gliomas: a cross-sectional study"],"prefix":"10.1007","volume":"139","author":[{"given":"Chirag B.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Fazzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ararat","family":"Chakhoyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huytram","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Manoukian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhung","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy F.","family":"Cloughesy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phioanh L.","family":"Nghiemphu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Czernin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2764-6640","authenticated-orcid":false,"given":"Benjamin M.","family":"Ellingson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,20]]},"reference":[{"issue":"Suppl 4","key":"2877_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","volume":"17","author":"QT Ostrom","year":"2015","unstructured":"Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008\u20132012. Neuro Oncol 17(Suppl 4):iv1\u2013iv62","journal-title":"Neuro Oncol"},{"key":"2877_CR2","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1001\/jama.2015.16669","volume":"314","author":"R Stupp","year":"2015","unstructured":"Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, Taylor LP, Lieberman F, Silvani A, Fink KL, Barnett GH, Zhu JJ, Henson JW, Engelhard HH, Chen TC, Tran DD, Sroubek J, Tran ND, Hottinger AF, Landolfi J, Desai R, Caroli M, Kew Y, Honnorat J, Idbaih A, Kirson ED, Weinberg U, Palti Y, Hegi ME, Ram Z (2015) Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA 314:2535\u20132543","journal-title":"JAMA"},{"key":"2877_CR3","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1093\/neuonc\/now046","volume":"18","author":"OL Chinot","year":"2016","unstructured":"Chinot OL, Nishikawa R, Mason W, Henriksson R, Saran F, Cloughesy T, Garcia J, Revil C, Abrey L, Wick W (2016) Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglio. Neuro Oncol 18:1313\u20131318","journal-title":"Neuro Oncol"},{"key":"2877_CR4","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","volume":"318","author":"R Stupp","year":"2017","unstructured":"Stupp R, Taillibert S, Kanner A, Read W, Steinberg DM, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K, Di Meco F, Lieberman F, Zhu JJ, Stragliotto G, Tran DD, Brem S, Hottinger AF, Kirson ED, Lavy-Shahaf G, Weinberg U, Kim CY, Paek SH, Nicholas G, Burna J, Hirte H, Weller M, Palti Y, Hegi ME, Ram Z (2017) Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. JAMA 318:2306\u20132316","journal-title":"JAMA"},{"issue":"4","key":"2877_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/neuonc\/nox193","volume":"20","author":"BM Ellingson","year":"2018","unstructured":"Ellingson BM, Wen PY, Cloughesy TF (2018) Evidence and context of use for contrast enhancement as a surrogate of disease burden and treatment response in malignant glioma. Neuro Oncol 20(4):457\u2013471","journal-title":"Neuro Oncol"},{"key":"2877_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/1754-9485.12421","volume":"60","author":"A Lasocki","year":"2016","unstructured":"Lasocki A, Gaillard F, Tacey M, Drummond K, Stuckey S (2016) Incidence and prognostic significance of non-enhancing cortical signal abnormality in glioblastoma. J Med Imaging Radiat Oncol 60:66\u201373","journal-title":"J Med Imaging Radiat Oncol"},{"key":"2877_CR7","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/RLU.0000000000001540","volume":"42","author":"C Bund","year":"2017","unstructured":"Bund C, Heimburger C, Imperiale A, Lhermitte B, Chenard MP, Lefebvre F, Kremer S, Proust F, Namer IJ (2017) FDOPA PET-CT of nonenhancing brain tumors. Clin Nucl Med 42:250\u2013257","journal-title":"Clin Nucl Med"},{"key":"2877_CR8","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/neuonc\/now058","volume":"18","author":"NL Albert","year":"2016","unstructured":"Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM, la Fougere C, Pope W, Law I, Arbizu J, Chamberlain MC, Vogelbaum M, Ellingson BM, Tonn JC (2016) Response assessment in neuro-oncology working group and European association for neuro-oncology recommendations for the clinical use of PET imaging in gliomas. Neuro Oncol 18:1199\u20131208","journal-title":"Neuro Oncol"},{"key":"2877_CR9","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.2967\/jnumed.109.065904","volume":"50","author":"RT Ullrich","year":"2009","unstructured":"Ullrich RT, Kracht L, Brunn A, Herholz K, Frommolt P, Miletic H, Deckert M, Heiss WD, Jacobs AH (2009) Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma. J Nucl Med 50:1962\u20131968","journal-title":"J Nucl Med"},{"key":"2877_CR10","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.2967\/jnumed.111.102533","volume":"53","author":"T Singhal","year":"2012","unstructured":"Singhal T, Narayanan TK, Jacobs MP, Bal C, Mantil JC (2012) 11C-methionine PET for grading and prognostication in gliomas: a comparison study with 18F-FDG PET and contrast enhancement on MRI. J Nucl Med 53:1709\u20131715","journal-title":"J Nucl Med"},{"key":"2877_CR11","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3174\/ajnr.A3324","volume":"34","author":"T Nihashi","year":"2013","unstructured":"Nihashi T, Dahabreh IJ, Terasawa T (2013) Diagnostic accuracy of PET for recurrent glioma diagnosis: a meta-analysis. AJNR Am J Neuroradiol 34:944\u2013950 (S941\u2013911)","journal-title":"AJNR Am J Neuroradiol"},{"key":"2877_CR12","first-page":"904","volume":"47","author":"W Chen","year":"2006","unstructured":"Chen W, Silverman DH, Delaloye S, Czernin J, Kamdar N, Pope W, Satyamurthy N, Schiepers C, Cloughesy T (2006) 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med 47:904\u2013911","journal-title":"J Nucl Med"},{"key":"2877_CR13","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s00259-007-0534-y","volume":"34","author":"G Popperl","year":"2007","unstructured":"Popperl G, Kreth FW, Mehrkens JH, Herms J, Seelos K, Koch W, Gildehaus FJ, Kretzschmar HA, Tonn JC, Tatsch K (2007) FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading. Eur J Nucl Med Mol Imaging 34:1933\u20131942","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2877_CR14","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1097\/RLU.0b013e3182291b40","volume":"36","author":"ML Calcagni","year":"2011","unstructured":"Calcagni ML, Galli G, Giordano A, Taralli S, Anile C, Niesen A, Baum RP (2011) Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for glioma grading: assessment of individual probability of malignancy. Clin Nucl Med 36:841\u2013847","journal-title":"Clin Nucl Med"},{"key":"2877_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2967\/jnumed.112.109603","volume":"54","author":"M Rapp","year":"2013","unstructured":"Rapp M, Heinzel A, Galldiks N, Stoffels G, Felsberg J, Ewelt C, Sabel M, Steiger HJ, Reifenberger G, Beez T, Coenen HH, Floeth FW, Langen KJ (2013) Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma. J Nucl Med 54:229\u2013235","journal-title":"J Nucl Med"},{"key":"2877_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2967\/jnumed.111.096859","volume":"53","author":"V Dunet","year":"2012","unstructured":"Dunet V, Rossier C, Buck A, Stupp R, Prior JO (2012) Performance of 18F-fluoro-ethyl-tyrosine (18F-FET) PET for the differential diagnosis of primary brain tumor: a systematic review and Metaanalysis. J Nucl Med 53:207\u2013214","journal-title":"J Nucl Med"},{"key":"2877_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2967\/jnumed.111.095711","volume":"53","author":"F Walter","year":"2012","unstructured":"Walter F, Cloughesy T, Walter MA, Lai A, Nghiemphu P, Wagle N, Fueger B, Satyamurthy N, Phelps ME, Czernin J (2012) Impact of 3,4-dihydroxy-6-18F-fluoro-L-phenylalanine PET\/CT on managing patients with brain tumors: the referring physician\u2019s perspective. J Nucl Med 53:393\u2013398","journal-title":"J Nucl Med"},{"key":"2877_CR18","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.nucmedbio.2015.06.001","volume":"42","author":"C Bell","year":"2015","unstructured":"Bell C, Dowson N, Puttick S, Gal Y, Thomas P, Fay M, Smith J, Rose S (2015) Increasing feasibility and utility of (18)F-FDOPA PET for the management of glioma. Nucl Med Biol 42:788\u2013795","journal-title":"Nucl Med Biol"},{"key":"2877_CR19","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.2967\/jnumed.110.078592","volume":"51","author":"BJ Fueger","year":"2010","unstructured":"Fueger BJ, Czernin J, Cloughesy T, Silverman DH, Geist CL, Walter MA, Schiepers C, Nghiemphu P, Lai A, Phelps ME, Chen W (2010) Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas. J Nucl Med 51:1532\u20131538","journal-title":"J Nucl Med"},{"key":"2877_CR20","first-page":"5117","volume":"35","author":"V Villani","year":"2015","unstructured":"Villani V, Carapella CM, Chiaravalloti A, Terrenato I, Piludu F, Vidiri A, Schillaci O, Floris R, Marzi S, Fabi A, Pace A (2015) The role of PET [18F]FDOPA in evaluating low-grade glioma. Anticancer Res 35:5117\u20135122","journal-title":"Anticancer Res"},{"key":"2877_CR21","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1093\/neuonc\/not002","volume":"15","author":"DH Pafundi","year":"2013","unstructured":"Pafundi DH, Laack NN, Youland RS, Parney IF, Lowe VJ, Giannini C, Kemp BJ, Grams MP, Morris JM, Hoover JM, Hu LS, Sarkaria JN, Brinkmann DH (2013) Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study. Neuro Oncol 15:1058\u20131067","journal-title":"Neuro Oncol"},{"key":"2877_CR22","first-page":"1180","volume":"37","author":"WD Heiss","year":"1996","unstructured":"Heiss WD, Wienhard K, Wagner R, Lanfermann H, Thiel A, Herholz K, Pietrzyk U (1996) F-Dopa as an amino acid tracer to detect brain tumors. J Nucl Med 37:1180\u20131182","journal-title":"J Nucl Med"},{"key":"2877_CR23","doi-asserted-by":"crossref","first-page":"e172-178","DOI":"10.3747\/co.21.1772","volume":"21","author":"N Dowson","year":"2014","unstructured":"Dowson N, Thomas P, Fay M, Jeffree RL, Gal Y, Bourgeat P, Smith J, Winter C, Coulthard A, Salvado O, Crozier S, Rose S (2014) Early prediction of treatment response in advanced gliomas with (18)F-dopa positron-emission tomography. Curr Oncol 21:e172-178","journal-title":"Curr Oncol"},{"key":"2877_CR24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/RLU.0000000000000897","volume":"40","author":"L Janvier","year":"2015","unstructured":"Janvier L, Olivier P, Blonski M, Morel O, Vignaud JM, Karcher G, Taillandier L, Verger A (2015) Correlation of SUV-derived indices with tumoral aggressiveness of gliomas in static 18F-FDOPA PET: use in clinical practice. Clin Nucl Med 40:e429\u2013435","journal-title":"Clin Nucl Med"},{"key":"2877_CR25","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.2967\/jnumed.114.140608","volume":"55","author":"C Lapa","year":"2014","unstructured":"Lapa C, Linsenmann T, Monoranu CM, Samnick S, Buck AK, Bluemel C, Czernin J, Kessler AF, Homola GA, Ernestus RI, Lohr M, Herrmann K (2014) Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients. J Nucl Med 55:1611\u20131616","journal-title":"J Nucl Med"},{"key":"2877_CR26","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ejrad.2008.04.018","volume":"71","author":"CJ Ledezma","year":"2009","unstructured":"Ledezma CJ, Chen W, Sai V, Freitas B, Cloughesy T, Czernin J, Pope W (2009) 18F-FDOPA PET\/MRI fusion in patients with primary\/recurrent gliomas: initial experience. Eur J Radiol 71:242\u2013248","journal-title":"Eur J Radiol"},{"key":"2877_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/RLU.0b013e318279fd5a","volume":"38","author":"C Nioche","year":"2013","unstructured":"Nioche C, Soret M, Gontier E, Lahutte M, Dutertre G, Dulou R, Capelle L, Guillevin R, Foehrenbach H, Buvat I (2013) Evaluation of quantitative criteria for glioma grading with static and dynamic 18F-FDopa PET\/CT. Clin Nucl Med 38:81\u201387","journal-title":"Clin Nucl Med"},{"key":"2877_CR28","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3174\/ajnr.A3315","volume":"34","author":"S Rose","year":"2013","unstructured":"Rose S, Fay M, Thomas P, Bourgeat P, Dowson N, Salvado O, Gal Y, Coulthard A, Crozier S (2013) Correlation of MRI-derived apparent diffusion coefficients in newly diagnosed gliomas with [18F]-fluoro-L-dopa PET: what are we really measuring with minimum ADC? Am J Neuroradiol 34:758\u2013764","journal-title":"Am J Neuroradiol"},{"key":"2877_CR29","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.2967\/jnumed.106.039321","volume":"48","author":"C Schiepers","year":"2007","unstructured":"Schiepers C, Chen W, Cloughesy T, Dahlbom M, Huang SC (2007) 18F-FDOPA kinetics in brain tumors. J Nucl Med 48:1651\u20131661","journal-title":"J Nucl Med"},{"key":"2877_CR30","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1097\/RLU.0b013e3181becfe0","volume":"34","author":"M Tripathi","year":"2009","unstructured":"Tripathi M, Sharma R, D\u2019Souza M, Jaimini A, Panwar P, Varshney R, Datta A, Kumar N, Garg G, Singh D, Grover RK, Mishra AK, Mondal A (2009) Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET\/CT for metabolic imaging of low grade gliomas. Clin Nucl Med 34:878\u2013883","journal-title":"Clin Nucl Med"},{"key":"2877_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/neuonc\/now187","volume":"19","author":"BM Ellingson","year":"2017","unstructured":"Ellingson BM, Harris RJ, Woodworth DC, Leu K, Zaw O, Mason WP, Sahebjam S, Abrey LE, Aftab DT, Schwab GM, Hessel C, Lai A, Nghiemphu PL, Pope WB, Wen PY, Cloughesy TF (2017) Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials. Neuro Oncol 19:89\u201398","journal-title":"Neuro Oncol"},{"key":"2877_CR32","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1148\/radiol.13131305","volume":"271","author":"BM Ellingson","year":"2014","unstructured":"Ellingson BM, Kim HJ, Woodworth DC, Pope WB, Cloughesy JN, Harris RJ, Lai A, Nghiemphu PL, Cloughesy TF (2014) Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial. Radiology 271:200\u2013210","journal-title":"Radiology"},{"key":"2877_CR33","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/neuonc\/not198","volume":"16","author":"AN Tran","year":"2014","unstructured":"Tran AN, Lai A, Li S, Pope WB, Teixeira S, Harris RJ, Woodworth DC, Nghiemphu PL, Cloughesy TF, Ellingson BM (2014) Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry. Neuro Oncol 16:414\u2013420","journal-title":"Neuro Oncol"},{"key":"2877_CR34","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1118\/1.598392","volume":"25","author":"PE Kinahan","year":"1998","unstructured":"Kinahan PE, Townsend DW, Beyer T, Sashin D (1998) Attenuation correction for a combined 3D PET\/CT scanner. Med Phys 25:2046\u20132053","journal-title":"Med Phys"},{"key":"2877_CR35","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1109\/42.925290","volume":"20","author":"J Nuyts","year":"2001","unstructured":"Nuyts J, Michel C, Dupont P (2001) Maximum-likelihood expectation-maximization reconstruction of sinograms with arbitrary noise distribution using NEC-transformations. IEEE Trans Med Imaging 20:365\u2013375","journal-title":"IEEE Trans Med Imaging"},{"key":"2877_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-018-2821-9","author":"M Ideguchi","year":"2018","unstructured":"Ideguchi M, Nishizaki T, Ikeda N, Okamura T, Tanaka Y, Fujii N, Ohno M, Shimabukuro T, Kimura T, Ikeda E, Suga K (2018) A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement. J Neurooncol. https:\/\/doi.org\/10.1007\/s11060-018-2821-9","journal-title":"J Neurooncol"},{"key":"2877_CR37","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1007\/s00259-017-3668-6","volume":"44","author":"A Verger","year":"2017","unstructured":"Verger A, Metellus P, Sala Q, Colin C, Bialecki E, Taieb D, Chinot O, Figarella-Branger D, Guedj E (2017) IDH mutation is paradoxically associated with higher (18)F-FDOPA PET uptake in diffuse grade II and grade III gliomas. Eur J Nucl Med Mol Imaging 44:1306\u20131311","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2877_CR38","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1292\/jvms.11-0353","volume":"74","author":"H Ochiai","year":"2012","unstructured":"Ochiai H, Morishita T, Onda K, Sugiyama H, Maruo T (2012) Canine Lat1: molecular structure, distribution and its expression in cancer samples. J Vet Med Sci 74:917\u2013922","journal-title":"J Vet Med Sci"},{"key":"2877_CR39","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1097\/00004647-200011000-00005","volume":"20","author":"R Duelli","year":"2000","unstructured":"Duelli R, Enerson BE, Gerhart DZ, Drewes LR (2000) Expression of large amino acid transporter LAT1 in rat brain endothelium. J Cereb Blood Flow Metab 20:1557\u20131562","journal-title":"J Cereb Blood Flow Metab"},{"key":"2877_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11060-012-0986-1","volume":"111","author":"RS Youland","year":"2013","unstructured":"Youland RS, Kitange GJ, Peterson TE, Pafundi DH, Ramiscal JA, Pokorny JL, Giannini C, Laack NN, Parney IF, Lowe VJ, Brinkmann DH, Sarkaria JN (2013) The role of LAT1 in (18)F-DOPA uptake in malignant gliomas. J Neurooncol 111:11\u201318","journal-title":"J Neurooncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-018-2877-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-018-2877-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-018-2877-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T10:52:03Z","timestamp":1660992723000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-018-2877-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,20]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["2877"],"URL":"https:\/\/doi.org\/10.1007\/s11060-018-2877-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,20]]},"assertion":[{"value":"2 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}